{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:56:26Z","timestamp":1794362186210,"version":"4.9.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI072648"],"award-info":[{"award-number":["AI072648"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI122176"],"award-info":[{"award-number":["AI122176"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["AR076092"],"award-info":[{"award-number":["AR076092"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.autrev.2021.102984","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T01:09:07Z","timestamp":1635383347000},"page":"102984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan"],"prefix":"10.1016","volume":"20","author":[{"given":"Christian","family":"Geier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102984_bb0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102984_bb0010","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1534\/genetics.111.133363","article-title":"Target of Rapamycin (TOR) in nutrient signaling and growth control","volume":"189","author":"Loewith","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.autrev.2021.102984_bb0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0955-0674(97)80078-6","article-title":"TOR signalling and control of cell growth","volume":"9","author":"Thomas","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.autrev.2021.102984_bb0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0025","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar3938","article-title":"ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer","volume":"4","author":"Harwood","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2021.102984_bb0035","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.18632\/oncotarget.3006","article-title":"Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2021.102984_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102984_bb0055","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0060","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1523\/JNEUROSCI.2423-05.2005","article-title":"The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the Hippocampus","volume":"25","author":"Banko","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2021.102984_bb0065","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1038\/s41467-018-05449-1","article-title":"Phosphorylation of ULK1 affects autophagosome fusion and links chaperone-mediated autophagy to macroautophagy","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102984_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.autrev.2021.102984_bb0075","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2021.102984_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nn.3351","article-title":"mTORC2 controls actin polymerization required for consolidation of long-term memory","volume":"16","author":"Huang","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2021.102984_bb0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0095","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.1147379","article-title":"Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38","volume":"318","author":"Bai","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102984_bb0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.autrev.2021.102984_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","article-title":"IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0110","first-page":"633","article-title":"IKK\u03b2 suppression of TSC1 function links the mTOR pathway with insulin resistance","volume":"22","author":"Lee","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2021.102984_bb0115","article-title":"Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102984_bb0120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0125","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.208017","article-title":"Rheb localized on the Golgi membrane activates lysosome-localized mTORC1 at the Golgi-lysosome contact site","volume":"131","author":"Hao","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0130","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2012.07.032","article-title":"Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1","volume":"150","author":"Bar-Peled","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-rag complex targets mTORC1 to the Lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102984_bb0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00239-011-9469-9","article-title":"Evolution of the TOR pathway","volume":"73","author":"van Dam","year":"2011","journal-title":"J Mol Evol"},{"key":"10.1016\/j.autrev.2021.102984_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0150","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102984_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of Rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.102984_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nature06421","article-title":"Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis","volume":"450","author":"Sanjuan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102984_bb0170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/cdd.2009.40","article-title":"Toll-like receptors in control of immunological autophagy","volume":"16","author":"Delgado","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2021.102984_bb0175","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.0501190102","article-title":"Autophagy promotes MHC class II presentation of peptides from intracellular source proteins","volume":"102","author":"Dengjel","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/eji.200323730","article-title":"Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy","volume":"33","author":"Nimmerjahn","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0185","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood-2004-09-3556","article-title":"Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA","volume":"105","author":"D\u00f6rfel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102984_bb0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0195","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/01.tp.0000235433.03554.4f","article-title":"Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin","volume":"82","author":"Sordi","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2021.102984_bb0200","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.4049\/jimmunol.166.7.4278","article-title":"Cutting edge: in vivo identification of TCR redistribution and polarized IL-2 production by naive CD4 T cells","volume":"166","author":"Reichert","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0205","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1126\/science.1071065","article-title":"Dynamic imaging of T cell-dendritic cell interactions in lymph nodes","volume":"296","author":"Stoll","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102984_bb0210","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nri1245","article-title":"T-cell-antigen recognition and the immunological synapse","volume":"3","author":"Huppa","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","article-title":"Intersection of mTOR and STAT signaling in immunity","volume":"36","author":"Saleiro","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","article-title":"Metabolic switching and fuel choice during T-cell differentiation and memory development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.102984_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"mTOR, metabolism, and the regulation of T-cell differentiation and function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.102984_bb0230","doi-asserted-by":"crossref","first-page":"17876","DOI":"10.1073\/pnas.0909357106","article-title":"The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes","volume":"106","author":"Jenner","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0235","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"mTOR differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2021.102984_bb0240","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.1901480","article-title":"Regulatory T cell stability and migration are dependent on mTOR","volume":"205","author":"Vallion","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0245","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.autrev.2021.102984_bb0250","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.2019002792","article-title":"Increased mTOR activation in idiopathic multicentric Castleman disease","volume":"135","author":"Arenas","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102984_bb0255","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1172\/JCI126091","article-title":"Identifying and targeting pathogenic PI3K\/AKT\/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102984_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2021.102984_bb0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-018-0806-7","article-title":"Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity","volume":"565","author":"Karmaus","year":"2019","journal-title":"Nature"},{"issue":"185","key":"10.1016\/j.autrev.2021.102984_bb0270","first-page":"3919","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation","volume":"1950","author":"Haidinger","year":"2010","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.102984_bb0275","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3389\/fimmu.2018.03145","article-title":"Regulation of dendritic cell immune function and metabolism by cellular nutrient sensor mammalian target of Rapamycin (mTOR)","volume":"9","author":"Snyder","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102984_bb0280","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.aaj2155","article-title":"mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation","volume":"357","author":"Sinclair","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102984_bb0285","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1172\/JCI92079","article-title":"Tregs restrain dendritic cell autophagy to ameliorate autoimmunity","volume":"127","author":"Alissafi","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102984_bb0290","doi-asserted-by":"crossref","first-page":"E1495","DOI":"10.1073\/pnas.1717065115","article-title":"Effects of rapamycin on growth hormone receptor knockout mice","volume":"115","author":"Fang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.102984_bb0295","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102984_bb0300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/gerona\/glq178","article-title":"Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice","volume":"66A","author":"Miller","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102984_bb0310","doi-asserted-by":"crossref","first-page":"102571","DOI":"10.1016\/j.autrev.2020.102571","article-title":"Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies","volume":"19","author":"Fagone","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102984_bb0315","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102984_bb0320","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal Kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.autrev.2021.102984_bb0325","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102984_bb0330","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.102984_bb0335","doi-asserted-by":"crossref","first-page":"108410","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","volume":"215","author":"Sawalha","year":"2020","journal-title":"Clin Immunol Orlando FLA"},{"issue":"182","key":"10.1016\/j.autrev.2021.102984_bb0340","first-page":"2063","article-title":"Activation of mTOR controls the loss of TCR\u03b6 in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation","volume":"1950","author":"Fernandez","year":"2009","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.102984_bb0345","first-page":"332","article-title":"The mechanistic target of Rapamycin (mTOR): novel considerations as an antiviral treatment","volume":"17","author":"Maiese","year":"2020","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.autrev.2021.102984_bb0350","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102984_bb0355","doi-asserted-by":"crossref","first-page":"108544","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin Immunol Orlando FLA"},{"key":"10.1016\/j.autrev.2021.102984_bb0360","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.41084","article-title":"Targeting mechanistic target of Rapamycin complex 1 restricts proinflammatory T cell differentiation and ameliorates Takayasu arteritis","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.102984_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7684352","article-title":"Low-dose sirolimus immunoregulation therapy in patients with active rheumatoid arthritis: a 24-week follow-up of the randomized, open-label, parallel-controlled trial","volume":"2019","author":"Wen","year":"2019","journal-title":"J Immunol Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:24:30Z","timestamp":1761600270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1568997221002640"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102984","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102984"}}